Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 30, 2021 06:00 ET | Source: Genetron Holdings Limited

Genetron Health’s Co-Founder and Chief Scientific Officer Awarded International Prize for Translational Neuroscience 2021

BEIJING, Aug. 30, 2021 (GLOBE NEWSWIRE) -- Genetron Holdings Limited (“Genetron Health” or the “Company”, NASDAQ:GTH), a leading precision oncology platform company in China that specializes in...
August 24, 2021 07:23 ET | Source: Genetron Holdings Limited

Genetron Health Reports Second Quarter 2021 Unaudited Financial Results

BEIJING, Aug. 24, 2021 (GLOBE NEWSWIRE) -- Genetron Holdings Limited (“Genetron Health” or the “Company”, NASDAQ:GTH), a leading precision oncology platform company in China that specializes in...
August 23, 2021 17:00 ET | Source: Genetron Holdings Limited

Genetron Health to Host Calls Following Earnings and Participate in an Upcoming Investor Conference

BEIJING, Aug. 23, 2021 (GLOBE NEWSWIRE) -- Genetron Holdings Limited (“Genetron Health” or the “Company”, Nasdaq: GTH), a leading precision oncology platform company in China that specializes in...
August 23, 2021 07:00 ET | Source: Genetron Holdings Limited

Genetron Health Reaches Strategic Partnership with Yikon Genomics, Expanding S5 Platform’s Reach to Reproductive Health Field

BEIJING, Aug. 23, 2021 (GLOBE NEWSWIRE) -- Genetron Holdings Limited (“Genetron Health” or the “Company”, NASDAQ: GTH), a leading precision oncology platform company in China that specializes in...
August 11, 2021 08:00 ET | Source: Genetron Holdings Limited

Genetron Health to Announce Second Quarter 2021 Financial Results and Host Investor Call on August 24, 2021

BEIJING, Aug. 11, 2021 (GLOBE NEWSWIRE) -- Genetron Holdings Limited (“Genetron Health” or the “Company”, NASDAQ: GTH), a leading precision oncology platform company in China that specializes in...
August 11, 2021 07:21 ET | Source: Genetron Holdings Limited

Genetron Health Tops NCCL’s External Quality Assessment of NGS-based Comprehensive Genomic Profiling for Solid Tumors with Full Marks

BEIJING, Aug. 11, 2021 (GLOBE NEWSWIRE) -- Genetron Holdings Limited (“Genetron Health” or the “Company”, NASDAQ: GTH), a leading precision oncology platform company in China that specializes in...
July 29, 2021 04:35 ET | Source: Genetron Holdings Limited

Genetron Health Partners with Guizhou Province’s Dafang County to Lead Liver Cancer Early Screening Project

BEIJING, July 29, 2021 (GLOBE NEWSWIRE) -- Genetron Holdings Limited (“Genetron Health” or the “Company”, NASDAQ: GTH), a leading precision oncology platform company in China that specializes in...
July 26, 2021 06:00 ET | Source: Genetron Holdings Limited

AYVAKIT® (avapritinib) Companion Diagnostic Test Enters Priority Review and Approval Process in China

BEIJING, July 26, 2021 (GLOBE NEWSWIRE) -- Genetron Holdings Limited (“Genetron Health” or the “Company”, NASDAQ: GTH), today announced that its AYVAKIT® (avapritinib) companion diagnostic (CDx)...
July 13, 2021 08:30 ET | Source: Genetron Holdings Limited

Genetron Health Receives CE Mark for 8-Gene Lung Cancer Assay and Provides FDA Reference Panel Comparative Data of its SARS-CoV-2 RNA Test

BEIJING, July 13, 2021 (GLOBE NEWSWIRE) -- Genetron Holdings Limited (“Genetron Health” or the “Company”, NASDAQ:GTH), a leading precision oncology platform company in China that specializes in...
July 01, 2021 22:00 ET | Source: Genetron Holdings Limited

Genetron Health Enters into Platform Partnership with World Economic Forum

BEIJING, July 02, 2021 (GLOBE NEWSWIRE) -- Genetron Holdings Limited (“Genetron Health” or the “Company”, NASDAQ: GTH), a leading precision oncology platform company in China that specializes in...